Company profile CLNN

Clene Inc
Description of the company is not available.
Quarter analysis & expected interest

There is not enough data for Clene Inc. to provide analysis

Correlation between past revenue and Clene Inc. search interest

There is not enough data for Clene Inc. to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Clene Inc. to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 18:44:42.

After 39 days of this quarter the interest is at 38.0. Based on that we can calculate that during remaining 52 days it will total up to 89.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019174
24
-86.2% QoQ
37
54.2% QoQ
78
110.8% QoQ
2020 121
-30.5% YoY 55.1% QoQ
50
108.3% YoY -58.7% QoQ
181
389.2% YoY 262.0% QoQ
54
-30.8% YoY -70.2% QoQ
2021 201
66.1% YoY 272.2% QoQ
118
136.0% YoY -41.3% QoQ
120
-33.7% YoY 1.7% QoQ
74
37.0% YoY -38.3% QoQ
2022 100
-50.2% YoY 35.1% QoQ
56
-52.5% YoY -44.0% QoQ
357
197.5% YoY 537.5% QoQ
233
214.9% YoY -34.7% QoQ
2023 136
36.0% YoY -41.6% QoQ
170
203.6% YoY 25.0% QoQ
185
-48.2% YoY 8.8% QoQ
133
-42.9% YoY -28.1% QoQ
2024 38
-72.1% YoY -71.4% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and CNM-Au8 search interestLast update: February 08 2024 18:44:42.
Correlation coefficient between keyword and revenue is 0.54
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 18:44:43.

The average 5 years interest of CNM-Au8 was 10.11 per week.
The last year interest of CNM-Au8 compared to the last 5 years has changed by 19.29%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 44.43%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for CNM-AgZn17 to provide analysis

Correlation between past revenue and CNM-AgZn17 search interest

There is not enough data for CNM-AgZn17 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for CNM-AgZn17 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for CNM-ZnAg to provide analysis

Correlation between past revenue and CNM-ZnAg search interest

There is not enough data for CNM-ZnAg to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for CNM-ZnAg to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Clene Inc. clinical trials to provide analysis

Correlation between past revenue and Clene Inc. clinical trials search interest

There is not enough data for Clene Inc. clinical trials to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Clene Inc. clinical trials to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 21:38:21.

After 39 days of this quarter the interest is at 64.0. Based on that we can calculate that during remaining 52 days it will total up to 149.0.
Amyotrophic lateral sclerosis treatment expected interest is significantly lower compared to previous quarter (-44.2%) but similar to same quarter last year.

YearQ1Q2Q3Q4
2019105
182
73.3% QoQ
37
-79.7% QoQ
244
559.5% QoQ
2020 265
152.4% YoY 8.6% QoQ
0
-100.0% YoY -100.0% QoQ
87
135.1% YoY inf% QoQ
59
-75.8% YoY -32.2% QoQ
2021 131
-50.6% YoY 122.0% QoQ
32
inf% YoY -75.6% QoQ
164
88.5% YoY 412.5% QoQ
157
166.1% YoY -4.3% QoQ
2022 249
90.1% YoY 58.6% QoQ
190
493.8% YoY -23.7% QoQ
155
-5.5% YoY -18.4% QoQ
144
-8.3% YoY -7.1% QoQ
2023 246
-1.2% YoY 70.8% QoQ
282
48.4% YoY 14.6% QoQ
201
29.7% YoY -28.7% QoQ
267
85.4% YoY 32.8% QoQ
2024 64
-74.0% YoY -76.0% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Amyotrophic lateral sclerosis treatment search interestLast update: February 08 2024 21:38:19.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 21:38:26.

The average 5 years interest of Amyotrophic lateral sclerosis treatment was 12.49 per week.
The last year interest of Amyotrophic lateral sclerosis treatment compared to the last 5 years has changed by 50.28%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 46.76%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: November 09 2023 13:49:03.

After 34 days of this quarter the interest is at 192.0. Based on that we can calculate that during remaining 58 days it will total up to 520.0.
Parkinson's disease treatment expected interest is significantly higher compared to previous quarter (+100.0%) but similar to same quarter last year.

YearQ1Q2Q3Q4
2018 - - - 266
2019 500
88.0% QoQ
428
-14.4% QoQ
362
-15.4% QoQ
413
55.3% YoY 14.1% QoQ
2020 404
-19.2% YoY -2.2% QoQ
235
-45.1% YoY -41.8% QoQ
217
-40.1% YoY -7.7% QoQ
347
-16.0% YoY 59.9% QoQ
2021 250
-38.1% YoY -28.0% QoQ
161
-31.5% YoY -35.6% QoQ
216
-0.5% YoY 34.2% QoQ
271
-21.9% YoY 25.5% QoQ
2022 357
42.8% YoY 31.7% QoQ
324
101.2% YoY -9.2% QoQ
296
37.0% YoY -8.6% QoQ
461
70.1% YoY 55.7% QoQ
2023 480
34.5% YoY 4.1% QoQ
394
21.6% YoY -17.9% QoQ
260
-12.2% YoY -34.0% QoQ
192
-58.4% YoY -26.2% QoQ
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Parkinson's disease treatment search interestLast update: November 09 2023 13:49:03.
Correlation coefficient between keyword and revenue is -0.33
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: November 09 2023 13:49:04.

The average 5 years interest of Parkinson's disease treatment was 26.18 per week.
The last year interest of Parkinson's disease treatment compared to the last 5 years has changed by 12.91%.
The interest for Parkinson's disease treatment is seasonal.
The last year interest is comparable to 5 years ago. It has changed only by -13.54%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Visual pathway deficits treatment to provide analysis

Correlation between past revenue and Visual pathway deficits treatment search interest

There is not enough data for Visual pathway deficits treatment to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Visual pathway deficits treatment to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Clene Inc. stock price to provide analysis

Correlation between past revenue and Clene Inc. stock price search interest

There is not enough data for Clene Inc. stock price to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Clene Inc. stock price to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Clene Inc. news to provide analysis

Correlation between past revenue and Clene Inc. news search interest

There is not enough data for Clene Inc. news to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Clene Inc. news to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for CLNN
Earnings date: 2024-03-11 After close
Company name: Clene Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-14T12:00:00Z

GlobeNewswire
Clene Reports First Quarter 2026 Financial Results and Recent Operating Highlights

2026-05-05T12:45:00Z

GlobeNewswire
Clene Announces $7 Million Underwritten Offering of Common Stock

2026-05-05T12:00:00Z

GlobeNewswire
Clene to Present at Upcoming May Conferences

2026-05-04T16:54:21Z

Analyst Upgrades
HC Wainwright & Co. Reiterates Buy on Clene, Maintains $31 Price Target

2026-05-04T12:00:00Z

GlobeNewswire
After Successful FDA Meeting, Clene Filing Accelerated Approval NDA for ALS

2026-02-24T13:00:00Z

GlobeNewswire
Clene Issues Stockholder Letter Highlighting Upcoming CNM-Au8® 2026 Catalysts

2026-02-19T13:30:00Z

GlobeNewswire
Clene to Present at the Emerging Growth Conference

2026-01-20T12:00:00Z

GlobeNewswire
Presenting on Emerging Growth Conference 89 Day 1 on January 21; Register to live stream

2026-01-16T13:30:00Z

GlobeNewswire
Clene to Present at the Emerging Growth Conference

2026-01-12T13:30:00Z

GlobeNewswire
Clene Announces Additional CNM-Au8 Biomarker Data Supporting Potential NDA Filing for Upcoming In-Person FDA Meeting

2026-01-09T13:57:18Z

Analyst Upgrades
D. Boral Capital Maintains Buy on Clene, Maintains $23 Price Target

2026-01-09T13:30:00Z

GlobeNewswire
Clene Announces Registered Direct Offering of Over $28 Million

2025-12-10T12:48:51Z

Analyst Upgrades
D. Boral Capital Maintains Buy on Clene, Maintains $23 Price Target

2025-12-09T13:30:00Z

GlobeNewswire
Clene to Present at the Emerging Growth Conference

2025-12-03T20:21:24Z

Analyst Upgrades
D. Boral Capital Maintains Buy on Clene, Maintains $23 Price Target